Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00223964 · ClinicalTrials.gov registry record · Phase 4

Study of the Efficacy of Two Doses of Ferrlecit in the Treatment of Iron Deficiency in Pediatric Hemodialysis Patients

A Phase 4 study of Anemia, sponsored by Watson Pharmaceuticals.

Completed
Registry status
Phase 4
Development phase
59
Enrollment target
20
Study locations

NCT00223964 is a Phase 4 study of Anemia that has completed, run by Watson Pharmaceuticals. The registered enrollment target is 59 participants, below the 427-participant average among 72 other Anemia trials with a reported enrollment target (86% lower). The trial reports 20 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00223964, a Phase 4 study of Anemia, has completed, sponsored by Watson Pharmaceuticals.

COMPLETED
Registry status
Phase 4
Development phase
59 participants
Enrollment target
20
Study locations

Study Summary

This was a multi-center study in iron-deficient pediatric hemodialysis patients, whose legal guardian had provided signed informed consent and satisfied the inclusion and exclusion criteria.

Conditions Studied

Anemia

Interventions

  • DRUG Ferrlecit (sodium ferric gluconate complex in sucrose injection)

Study Locations (20)

Other

  • - Aruascalientes
  • - Mexico City
  • - Bialystok
  • - Gdansk
  • - Krakow
  • - Lodz
  • - Lublin
  • - Szczecin
  • - Torum
  • - Wroclaw
  • - Zabrze
  • - Bashkortostan

California

  • - Los Angeles
  • - San Diego
  • - Stanford

Alabama

  • - Birmingham

Massachusetts

  • - Boston

Missouri

  • - Kansas City

New York

  • - The Bronx

Washington

  • - Seattle

Trial Details

FieldValue
Enrollment Target 59 participants
Start Date 2003-06
Phase Phase 4

Sponsor

Watson Pharmaceuticals

28 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00223964

The ClinicalTrials.gov registry entry for NCT00223964 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 59 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 427-participant average among 72 other Anemia trials with a reported enrollment target (86% lower). The listed sponsor is Watson Pharmaceuticals, which has 28 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Anemia appearing as the primary indexed condition, and to 1 intervention - of which Ferrlecit (sodium ferric gluconate complex in sucrose injection) is the first listed.

NCT00223964 reports 20 study locations spanning 7 distinct geographic areas - top geographies include Other, California, Alabama.

Frequently Asked Questions

What is clinical trial NCT00223964 about?

NCT00223964 is a clinical study titled "Study of the Efficacy of Two Doses of Ferrlecit in the Treatment of Iron Deficiency in Pediatric Hemodialysis Patients". This was a multi-center study in iron-deficient pediatric hemodialysis patients, whose legal guardian had provided signed informed consent and satisfied the inclusion and exclusion criteria.

What is the current status of trial NCT00223964?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 59 participants. The study started on 2003-06.

What conditions does trial NCT00223964 study?

This clinical trial studies the following conditions: Anemia.

What interventions are being tested in trial NCT00223964?

The interventions under investigation include: Ferrlecit (sodium ferric gluconate complex in sucrose injection) (DRUG).

Who is sponsoring clinical trial NCT00223964?

This trial is sponsored by Watson Pharmaceuticals, which has 28 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00223964 being conducted?

This trial has 20 study locations across Alabama, California, Massachusetts, Missouri, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Anemia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Anemia

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.